It's hard to say estellaxxoo...
If I'm trading I may look at the mid $3's before selling out.
Other event driven opportunity, which in all probability looks positive is GSK's profit quarterly report.
That BTA is catching the eyes of larger investors and the absence of available stock will maintain a constant upward pressure on price.
